Positive results from early trial of drug that could protect brain cells
Date
News
Date
Foslevodopa-foscarbidopa (also called Produodopa) has been approved by NICE in England, Northern Ireland and Wales and the Scottish Medicines Consortium for people with Parkinson’s who experience movement related symptoms.
Date
Foslevodopa-foscarbidopa (also called Produodopa) can be offered in England from 27 February for people with Parkinson’s who experience movement related symptoms.
Date
Produodopa, a groundbreaking new treatment for advanced Parkinson’s, can now be prescribed in Scotland.
Date
Friday 8 March is International Women's Day and Parkinson's UK is celebrating all the inspirational women who either help to deliver our physical activity programmes, or have become physical activity advocates with Parkinson's.
Date
This week’s spring budget failed to offer much-needed support for people with Parkinson’s.
Date
A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
Date
At the end of March, the government’s cost of living support will come to an end. Yet our new research has found that for many people with Parkinson’s, the cost of living crisis is far from over.
Date
Predict-PD is a study that aims to understand the risk factors of Parkinson’s. More than 10,000 people are now taking part and are representative of the ethnic diversity within the UK population.
Date
Parkinson's UK has launched a series of new physical activity fitness videos to help more people get active online and to live well with the condition.
Date
The dates and venues for a new snooker project supported by Parkinson's UK and the World Professional Billiards and Snooker Association (WPBSA) have been announced.